Compounds > tetradecanoylphorbol acetate
Page last updated: 2024-08-23

tetradecanoylphorbol acetate and menaquinone 6

tetradecanoylphorbol acetate has been researched along with menaquinone 6 in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (60.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ma, ZJ; Yamaguchi, M1
Murata, K; Sakamoto, A1
Eguchi, Y; Fujimoto, K; Hamajima, H; Ide, Y; Kawaguchi, Y; Mizuta, T; Ozaki, I; Yamamoto, K; Zhang, H1
Eguchi, Y; Fujimoto, K; Hamajima, H; Iwane, S; Kuroda, S; Matsuhashi, S; Mizuta, T; Ozaki, I; Takahashi, H; Xia, J1
Anzai, K; Kuwashiro, T; Matsuhashi, S; Mizuta, T; Ozaki, I; Takahashi, H; Xia, J1

Other Studies

5 other study(ies) available for tetradecanoylphorbol acetate and menaquinone 6

ArticleYear
Inhibitory effect of menaquinone-7 (vitamin K2) on osteoclast-like cell formation and osteoclastic bone resorption in rat bone tissues in vitro.
    Molecular and cellular biochemistry, 2001, Volume: 228, Issue:1-2

    Topics: Animals; Bone and Bones; Bone Marrow Cells; Bone Resorption; Bucladesine; Calcitonin; Calcium; Carcinogens; Cells, Cultured; Dinoprostone; Enzyme Inhibitors; Hemostatics; Male; Osteoclasts; Oxytocics; Peptide Fragments; Rats; Rats, Wistar; Staurosporine; Teriparatide; Tetradecanoylphorbol Acetate; Vitamin K 2

2001
Impairment of clathrin-mediated endocytosis via cytoskeletal change by epithelial to fibroblastoid conversion in HepG2 cells: a possible mechanism of des-gamma-carboxy prothrombin production in hepatocellular carcinoma.
    International journal of oncology, 2008, Volume: 33, Issue:6

    Topics: Actins; Biomarkers; Biomarkers, Tumor; Bridged Bicyclo Compounds, Heterocyclic; Cadherins; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; Cell Transdifferentiation; Clathrin; Cytoskeleton; Dose-Response Relationship, Drug; Endocytosis; Epithelial Cells; Fibroblasts; Humans; Lipoproteins, LDL; Liver Neoplasms; Protein Precursors; Prothrombin; Tetradecanoylphorbol Acetate; Thiazolidines; Vitamin K 2

2008
Inhibition of matrix metalloproteinase expression by menatetrenone, a vitamin K2 analogue.
    Oncology reports, 2009, Volume: 22, Issue:3

    Topics: Carcinoma, Hepatocellular; Humans; Liver Neoplasms; MAP Kinase Signaling System; Matrix Metalloproteinase Inhibitors; Matrix Metalloproteinases; NF-kappa B; Protease Inhibitors; Protein Kinase C; Tetradecanoylphorbol Acetate; Transcription Factor AP-1; Vitamin K 2

2009
The role of PKC isoforms in the inhibition of NF-κB activation by vitamin K2 in human hepatocellular carcinoma cells.
    The Journal of nutritional biochemistry, 2012, Volume: 23, Issue:12

    Topics: Carcinoma, Hepatocellular; Cell Line, Tumor; Enzyme Inhibitors; Gene Knockdown Techniques; Humans; Indoles; Liver Neoplasms; Maleimides; NF-kappa B; Phosphorylation; Protein Kinase C; Protein Kinase C-delta; Protein Kinase C-epsilon; RNA, Small Interfering; Tetradecanoylphorbol Acetate; Vitamin K 2

2012
Mechanisms of PKC-Mediated Enhancement of HIF-1α Activity and its Inhibition by Vitamin K2 in Hepatocellular Carcinoma Cells.
    International journal of molecular sciences, 2019, Feb-26, Volume: 20, Issue:5

    Topics: Carcinoma, Hepatocellular; Cell Hypoxia; Cell Line, Tumor; Cell Nucleus; Gene Knockdown Techniques; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Isoenzymes; Liver Neoplasms; Promoter Regions, Genetic; Protein Kinase C; Protein Transport; Tetradecanoylphorbol Acetate; Vascular Endothelial Growth Factor A; Vitamin K 2

2019